PHILADELPHIA (AP) — Auditors reviewing the medical records of people slated to receive a share of a $3.75 billion trust fund for people who took the fen-phen diet drug have found "a huge number" that may not have suffered heart-valve damage as claimed, and shouldn't be paid, according to an attorney for the trust. More than 100,000 people have filed the paperwork and presumably telltale echocardiograms that would entitle them to a portion of the settlement fund, set up by Wyeth Inc. to resolve claims related to the recalled fen-phen drugs Pondimin and Redux. But payments to hundreds have been...